In8Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.41

-0.06 (-4.08%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +2,778.0% upside

Low Target $25.27

Average Target $40.58

High Target $56.74

Current Price $1.41

Current
$1.41

Target
$40.58

$25.27 $40.58 avg $56.74

Scenario Analysis

Bear Case

$25.27

1,692.2%

Low target

Base Case

$40.58

+2,778.0%

Avg target

Bull Case

$56.74

+3,924.1%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$6.66

-78.8% from high

52-Week Low

$1.17

+20.5% from low

Target vs 52W High

$40.58

+509.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%